WASHINGTON – A late-term maneuver by President Donald Trump to use lower drug prices paid overseas to limit some of Medicare's own costs suffered a legal setback Wednesday that appears likely to keep the policy from taking effect before the president leaves office.U.S.
District Judge Catherine C. Blake in Baltimore issued a nationwide injunction that prevents the Centers for Medicare and Medicaid Services, or CMS, from carrying out the so-called “most favored nations” rule as scheduled on Jan.